MCAF1 and synergistic activation of the transcription of Epstein-Barr virus lytic genes by Rta and Zta

Nucleic Acids Research

Volumn 38, Issue 14, 2010, Pages 4687-4700

  Chang, Li Kwan ^a   Chuang, Jian Ying ^a   Nakao, Mitsuyoshi ^b   Liu, Shih Tung ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; IMMEDIATE EARLY PROTEIN BZLF1; PROTEIN MCAF1; PROTEIN RTA; UNCLASSIFIED DRUG; VIRUS PROTEIN; BRLF1 PROTEIN, HUMAN HERPESVIRUS 4; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; IMMEDIATE EARLY PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; BINDING SITE; CELL LINE; CHEMISTRY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; PROTEIN DOMAIN; TRANSCRIPTION INITIATION;

HUMAN HERPESVIRUS 4;

BINDING SITES; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; IMMEDIATE-EARLY PROTEINS; IMMUNOPRECIPITATION; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION DOMAINS AND MOTIFS; RESPONSE ELEMENTS; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; VIRAL PROTEINS;

EID: 77955794374     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq243     Document Type: Article

References (34)

1. Chevallier-Greco,A., Manet,E., Chavrier,P., Mosnier,C., Daillie,J. and Sergeant,A. (1986) Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J., 5, 3243-3249.
2. Kenney,S., Holley-Guthrie,E., Mar,E.C. and Smith,M. (1989) The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol., 63, 38783883.
3. Holley-Guthrie,E.A., Quinlivan,E.B., Mar,E.C. and Kenney,S. (1990) The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J. Virol., 64, 3753-3759.
4. Giot,J.F., Mikaelian,I., Buisson,M., Manet,E., Joab,I., Nicolas,J.C. and Sergeant,A. (1991) Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Res., 19, 1251-1258.
5. Quinlivan,E.B., Holley-Guthrie,E.A., Norris,M., Gutsch,D., Bachenheimer,S.L. and Kenney,S.C. (1993) Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res., 21, 1999-2007.
6. Feederle,R., Kost,M., Baumann,M., Janz,A., Drouet,E., Hammerschmidt,W. and Delecluse,H.J. (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J., 19, 3080-3089.
7. Chiu,Y.F., Tung,C.P., Lee,Y.H., Wang,W.H., Li,C., Hung,J.Y., Wang,C.Y., Kawaguchi,Y. and Liu,S.T. (2007) A comprehensive library of mutations of Epstein Barr virus. J. Gen. Virol., 88, 2463-2472.
8. Chevallier-Greco,A., Gruffat,H., Manet,E., Calender,A. and Sergeant,A. (1989) The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. J. Virol., 63, 615-623.
9. Cox,M.A., Leahy,J. and Hardwick,J.M. (1990) An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol., 64, 313-321.
10. Chen,L.W., Chang,P.J., Delecluse,H.J. and Miller,G. (2005) Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus. J. Virol., 79, 9635-9650.
11. Granato,M., Farina,A., Gonnella,R., Santarelli,R., Frati,L., Faggioni,A. and Angeloni,A. (2006) Regulation of the expression of the Epstein-Barr virus early gene BFRF1. Virology, 347, 109-116.
12. Chang,L.K., Chung,J.Y., Hong,Y.R., Ichimura,T., Nakao,M. and Liu,S.T. (2005) Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res., 33, 6528-6539.
13. Ragoczy,T. and Miller,G. (2001) Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J. Virol., 75, 5240-5251.
14. Ragoczy,T. and Miller,G. (1999) Role of the Epstein-Barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. J. Virol., 73, 9858-9866.
15. Chua,H.H., Lee,H.H., Chang,S.S., Lu,C.C., Yeh,T.H., Hsu,T.Y., Cheng,T.H., Cheng,J.T., Chen,M.R. and Tsai,C.H. (2007) Role of the TSG101 gene in Epstein-Barr virus late gene transcription. J. Virol., 81, 2459-2471.
16. El-Guindy,A.S. and Miller,G. (2004) Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta. J. Virol., 78, 7634-7644.
17. Gruffat,H., Moreno,N. and Sergeant,A. (1990) The Epstein-Barr virus (EBV) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z. J. Virol., 64, 2810-2818.
18. Liu,P. and Speck,S.H. (2003) Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta. Virology, 310, 199-206.
19. Francis,A., Ragoczy,T., Gradoville,L., Heston,L., El-Guindy,A., Endo,Y. and Miller,G. (1999) Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator. J. Virol., 73, 4543-4551.
20. Ragoczy,T., Heston,L. and Miller,G. (1998) The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J. Virol., 72, 7978-7984.
21. Wang,H., An,W., Cao,R., Xia,L., Erdjument-Bromage,H., Chatton,B., Tempst,P., Roeder,R.G. and Zhang,Y. (2003) mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol. Cell, 12, 475-487.
22. Ichimura,T., Watanabe,S., Sakamoto,Y., Aoto,T., Fujita,N. and Nakao,M. (2005) Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins. J. Biol. Chem., 280, 13928-13935.
23. Fujita,N., Watanabe,S., Ichimura,T., Ohkuma,Y., Chiba,T., Saya,H. and Nakao,M. (2003) MCAF mediates MBD1-dependent transcriptional repression. Mol. Cell Biol., 23, 2834-2843.
24. Liu,L., Ishihara,K., Ichimura,T., Fujita,N., Hino,S., Tomita,S., Watanabe,S., Saitoh,N., Ito,T. and Nakao,M. (2009) MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity. J. Biol. Chem., 284, 5165-5174.
25. Chang,L.K., Lee,Y.H., Cheng,T.S., Hong,Y.R., Lu,P.J., Wang,J.J., Wang,W.H., Kuo,C.W., Li,S.S. and Liu,S.T. (2004) Post-translational modification of Rta of Epstein-Barr virus by SUMO-1. J. Biol. Chem., 279, 38803-38812.
26. Philipsen,S. and Suske,G. (1999) A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res., 27, 2991-3000.
27. Chang,L.K., Liu,S.T., Kuo,C.W., Wang,W.H., Chuang,J.Y., Bianchi,E. and Hong,Y.R. (2008) Enhancement of transactivation activity of Rta of Epstein-Barr virus by RanBPM. J. Mol. Biol., 379, 231-242.
28. Chang,L.K. and Liu,S.T. (2000) Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res., 28, 3918-3925.
29. Chang,P.J., Chang,Y.S. and Liu,S.T. (1998) Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus. J. Virol., 72, 5128-5136.
30. Kenney,S., Holley-Guthrie,E., Mar,E.C. and Smith,M. (1989) The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol., 63, 3878-3883.
31. Manet,E., Rigolet,A., Gruffat,H., Giot,J.F. and Sergeant,A. (1991) Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation. Nucleic Acids Res., 19, 2661-2667.
32. Kim,J.M., Hong,Y. and Kim,S. (2000) Artificial recruitment of Sp1 or TBP can replace the role of IE1 in the synergistic transactivation by IE1 and IE2. Biochem. Biophys. Res. Commun., 269, 302-308.
33. Lukac,D.M., Manuppello,J.R. and Alwine,J.C. (1994) Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex. J. Virol., 68, 5184-5193.
34. Dorr,A., Kiermer,V., Pedal,A., Rackwitz,H.R., Henklein,P., Schubert,U., Zhou,M.M., Verdin,E. and Ott,M. (2002) Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J., 21, 2715-2723.